IP Library Granted Patent US 9,693,801
Granted Patent B2
US 9,693,801 · App. 14/377,149 · Granted Jul 4, 2017

Releasably securable needle and handle system and method

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,693,801
App. No.
14/377,149
Granted
Jul 4, 2017
Kind
B2
Abstract

An implant and needle delivery system including a needle selectively releasable from a handle assembly is provided. The needle is selectively connectable with an elongate sling and the needle is selectively releasable from the handle assembly an implantation procedure to treat a pelvic disorder or condition, such as incontinence.

Claims (28)

1. A delivery needle system, comprising:

a needle including a proximal end portion and a distal end portion, the proximal end portion having a retention tip; and

a handle assembly including a body portion and a release sleeve, the body portion having an interior needle channel and a retention clip, wherein the proximal end portion of the needle traverses the interior needle channel and is selectively releasable from the retention clip, with the release sleeve including a shaft portion having a retention arm to selectively seat within the body portion.

2. The system of claim 1 , wherein the retention arm has at least one opening selectively engaged with the retention clip such that disengagement of the retention arm with the retention clip facilitates releasing the proximal end portion of the needle from the retention clip to permit disengagement of the needle from the handle assembly.

3. The system of claim 1 , wherein the retention clip includes one or more extending fingers to selectively engage the proximal end portion of the needle.

4. The system of claim 3 , wherein the one or more extending fingers includes one or more end tab portions.

5. The system of claim 1 , wherein the retention clip includes one or more extending fingers capable of deforming to selectively release the proximal end portion of the needle.

6. The system of claim 1 , wherein at least a portion of the needle is curved.

7. The system of claim 1 , further including an actuator adapted to operatively release the proximal end portion of the needle from the retention clip.

8. The system of claim 7 , wherein the actuator is a button device.

9. The system of claim 1 , further including an elongate sling implant having an end connector to selectively connect with the distal end portion of the needle.

10. A delivery needle system, comprising:

a needle including a proximal end portion and a distal end portion, the proximal end portion having a retention tip; and

a handle assembly including a body portion, an actuator, and a separate sleeve portion, the body portion having an interior needle channel and a retention clip, wherein the proximal end portion of the needle traverses the interior needle channel and the retention tip is selectively engageable with the retention clip such that actuation of the actuator disengages the retention clip from the retention tip of the needle, the separate sleeve portion including an extending portion selectively engageable within the interior needle channel of the body portion.

11. The system of claim 10 , further including a retention arm having at least one opening selectively engaged with the retention clip such that the actuator operatively engages the retention arm and facilitates releasing the retention tip of the needle from the retention clip to permit disengagement of the needle from the handle assembly.

12. The system of claim 10 , wherein the retention clip includes one or more extending fingers to selectively engage the retention clip and the retention tip of the needle.

13. The system of claim 12 , wherein the one or more extending fingers includes one or more end tab portions.

14. The system of claim 10 , wherein at least a portion of the needle is curved.

15. The system of claim 10 , wherein the actuator is a depressable button device.

16. The system of claim 10 , further including an elongate sling implant having an end connector to selectively connect with the distal end portion of the needle.

17. The system of claim 10 , wherein the retention tip of the needle is a bulbous tip portion.

18. A surgical implant system, comprising:

an elongate sling implant having opposing end connectors;

a needle including a proximal end portion and a distal end portion, the proximal end portion having a generally bulbous end tip; and

a handle assembly including a sleeve portion, a body portion, an actuator, and an axially traversable release arm, the body portion having an interior needle channel and a retention clip, wherein the proximal end portion of the needle and the axially traversable release arm are selectively engageable with the retention clip such that actuation of the actuator disengages the release arm from the retention clip and correspondingly the proximal end portion of the needle from the retention clip, with a portion of the sleeve portion extending into and engageable within the body portion.

19. The system of claim 18 , wherein the retention clip includes one or more deformable extending fingers.

20. The system of claim 18 , wherein at least a portion of the needle is curved.

21. The system of claim 18 , wherein the actuator is a depressable button device.

Assignments (9)
RELEASE OF SECURITY INTEREST Recorded Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO GENERIC HOLDINGS, INC. (FORMERLY KNOWN AS PAR PHARMACEUTICALS COMPANIES, INC.); ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067240/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 7, 2017
From: BOSTON SCIENTIFIC CORPORATION
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 043778/0167 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 7, 2017
From: ASTORA WOMEN'S HEALTH, LLC; ENDO HEALTH SOLUTIONS INC.; ASTORA WOMEN'S HEALTH HOLDINGS, LLC
To: BOSTON SCIENTIFIC CORPORATION
Reel/Frame 043777/0895 →
SECURITY INTEREST Recorded Jun 8, 2017
From: ASTORA WOMEN'S HEALTH, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE
Reel/Frame 042743/0278 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY DATA; PREVIOUSLY RECORDED ON REEL 037300 FRAME 0199. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Feb 25, 2016
From: AMS RESEARCH CORPORATION
To: AMS RESEARCH, LLC
Reel/Frame 037916/0028 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2016
From: AMS RESEARCH, LLC
To: APHRODITE WOMEN'S HEALTH, LLC
Reel/Frame 037473/0745 →
CHANGE OF NAME Recorded Jan 11, 2016
From: APHRODITE WOMEN'S HEALTH, LLC
To: ASTORA WOMEN'S HEALTH, LLC
Reel/Frame 037473/0919 →
CHANGE OF NAME Recorded Dec 15, 2015
From: AMS RESEARCH CORPATION
To: AMS RESEARCH, LLC
Reel/Frame 037300/0199 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 6, 2014
From: ALLEN, JOHN J.
To: AMS RESEARCH CORPORATION
Reel/Frame 033480/0793 →